vs
Side-by-side financial comparison of Axos Financial, Inc. (AX) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Axos Financial, Inc. is the larger business by last-quarter revenue ($385.1M vs $207.8M, roughly 1.9× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 33.3%, a 24.0% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $85.4M).
Axos Financial is an American bank holding company based in Las Vegas, Nevada and is the parent of Axos Bank, a direct bank. It also offers registered investment adviser services and an electronic trading platform.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
AX vs IDYA — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $385.1M | $207.8M |
| Net Profit | $128.4M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 45.6% | 52.2% |
| Net Margin | 33.3% | 57.4% |
| Revenue YoY | 25.1% | — |
| Net Profit YoY | 22.6% | 330.1% |
| EPS (diluted) | $2.22 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $385.1M | — | ||
| Q3 25 | $323.4M | $207.8M | ||
| Q2 25 | $321.4M | — | ||
| Q1 25 | $308.8M | — | ||
| Q4 24 | $307.9M | — | ||
| Q3 24 | $320.7M | $0 | ||
| Q2 24 | $290.9M | $0 | ||
| Q1 24 | $294.8M | $0 |
| Q4 25 | $128.4M | — | ||
| Q3 25 | $112.4M | $119.2M | ||
| Q2 25 | $110.7M | — | ||
| Q1 25 | $105.2M | — | ||
| Q4 24 | $104.7M | — | ||
| Q3 24 | $112.3M | $-51.8M | ||
| Q2 24 | $104.9M | $-52.8M | ||
| Q1 24 | $110.7M | $-39.6M |
| Q4 25 | 45.6% | — | ||
| Q3 25 | 46.3% | 52.2% | ||
| Q2 25 | 48.5% | — | ||
| Q1 25 | 47.9% | — | ||
| Q4 24 | 48.8% | — | ||
| Q3 24 | 49.6% | — | ||
| Q2 24 | 49.6% | — | ||
| Q1 24 | 52.8% | — |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 34.7% | 57.4% | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 34.1% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 36.0% | — | ||
| Q1 24 | 37.6% | — |
| Q4 25 | $2.22 | — | ||
| Q3 25 | $1.94 | $1.33 | ||
| Q2 25 | $1.89 | — | ||
| Q1 25 | $1.81 | — | ||
| Q4 24 | $1.80 | — | ||
| Q3 24 | $1.93 | $-0.60 | ||
| Q2 24 | $1.75 | $-0.68 | ||
| Q1 24 | $1.91 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $1.1B |
| Total Assets | $28.2B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.0B | — | ||
| Q3 25 | $2.6B | $786.9M | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.6B | $920.0M | ||
| Q2 24 | $2.0B | $701.7M | ||
| Q1 24 | $2.1B | $698.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $312.7M | — | ||
| Q1 25 | $377.4M | — | ||
| Q4 24 | $358.7M | — | ||
| Q3 24 | $313.5M | — | ||
| Q2 24 | $325.7M | — | ||
| Q1 24 | $330.4M | — |
| Q4 25 | $2.9B | — | ||
| Q3 25 | $2.8B | $1.1B | ||
| Q2 25 | $2.7B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.4B | $1.2B | ||
| Q2 24 | $2.3B | $931.7M | ||
| Q1 24 | $2.2B | $935.3M |
| Q4 25 | $28.2B | — | ||
| Q3 25 | $27.4B | $1.2B | ||
| Q2 25 | $24.8B | — | ||
| Q1 25 | $24.0B | — | ||
| Q4 24 | $23.7B | — | ||
| Q3 24 | $23.6B | $1.2B | ||
| Q2 24 | $22.9B | $973.7M | ||
| Q1 24 | $22.6B | $961.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $104.1M | $142.2M |
| Free Cash FlowOCF − Capex | $85.4M | $142.2M |
| FCF MarginFCF / Revenue | 22.2% | 68.4% |
| Capex IntensityCapex / Revenue | 4.9% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.81× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $695.9M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.1M | — | ||
| Q3 25 | $118.4M | $142.2M | ||
| Q2 25 | $490.3M | — | ||
| Q1 25 | $73.7M | — | ||
| Q4 24 | $162.5M | — | ||
| Q3 24 | $70.8M | $-49.2M | ||
| Q2 24 | $305.5M | $-32.9M | ||
| Q1 24 | $115.8M | $-43.8M |
| Q4 25 | $85.4M | — | ||
| Q3 25 | $109.3M | $142.2M | ||
| Q2 25 | $436.1M | — | ||
| Q1 25 | $65.1M | — | ||
| Q4 24 | $156.4M | — | ||
| Q3 24 | $53.0M | $-49.7M | ||
| Q2 24 | $269.5M | $-33.9M | ||
| Q1 24 | $107.3M | $-45.1M |
| Q4 25 | 22.2% | — | ||
| Q3 25 | 33.8% | 68.4% | ||
| Q2 25 | 135.7% | — | ||
| Q1 25 | 21.1% | — | ||
| Q4 24 | 50.8% | — | ||
| Q3 24 | 16.5% | — | ||
| Q2 24 | 92.6% | — | ||
| Q1 24 | 36.4% | — |
| Q4 25 | 4.9% | — | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 16.9% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 2.9% | — |
| Q4 25 | 0.81× | — | ||
| Q3 25 | 1.05× | 1.19× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 1.55× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | 2.91× | — | ||
| Q1 24 | 1.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
